February 23, 2017 / 12:12 PM / 9 months ago

BRIEF-Sage Therapeutics posts Q4 loss per share of $1.50

Feb 23 (Reuters) - Sage Therapeutics Inc

* Sage Therapeutics announces fourth quarter and full year 2016 financial results and provides corporate update

* Expects existing cash, cash equivalents, to fund anticipated level of operations, based on its current operating plans, into Q2’ 18

* Qtrly loss per share $1.50 Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below